12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks showed significant movement. Eliem Therapeutics, Rallybio, and Alpine Immune Sciences were among the top gainers, with stock prices increasing by 51.6%, 49.07%, and 36.62% respectively. On the downside, Aptevo Therapeutics led the losers with a 55.0% decline in its stock price. Other notable decliners include SILO Pharma and Acorda Therapeutics.
April 11, 2024 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Aptevo Therapeutics stock declined by 55.0% to $1.08 in pre-market trading.
The sharp decline in Aptevo Therapeutics' stock price suggests negative news or market reactions, indicating potential short-term volatility or concerns.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Alpine Immune Sciences shares rose 36.62% to $64.27, with a market cap of $4.2 billion.
The significant rise in Alpine Immune Sciences' stock price could be attributed to investor optimism about the company's prospects, making it a key player in the healthcare sector.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Eliem Therapeutics stock surged 51.6% in pre-market trading, with a market value of $112.2 million.
The significant pre-market increase in Eliem Therapeutics' stock price indicates strong investor interest, potentially due to positive company news or market conditions favoring healthcare stocks.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Rallybio's stock price increased by 49.07% to $2.43, with a market cap of $91.8 million.
Rallybio's substantial stock price increase suggests positive developments or favorable market sentiment towards the company, making it a stock to watch in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90